Article Details

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST ...

Retrieved on: 2024-04-09 20:06:17

Tags for this article:

Click the tags to see associated articles and topics

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST .... View article details on HISWAI: https://www.marketscreener.com/quote/stock/FUSN-PHAR-108985405/news/Fusion-Pharmaceuticals-Announces-Presentation-of-Interim-Data-from-the-Phase-2-TATCIST-Clinical-Tria-46399079/

Excerpt

HAMILTON, ON and BOSTON , April 9, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up